 James Feinstein
Concepts (270)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polypharmacy | 12 | 2026 | 94 | 4.490 |
Why?
| | Nervous System Diseases | 8 | 2024 | 286 | 3.210 |
Why?
| | Epidermolysis Bullosa | 9 | 2025 | 69 | 2.990 |
Why?
| | Chronic Disease | 13 | 2026 | 1812 | 2.590 |
Why?
| | Medicaid | 11 | 2024 | 467 | 2.470 |
Why?
| | International Classification of Diseases | 6 | 2024 | 150 | 2.430 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 6 | 2024 | 261 | 1.940 |
Why?
| | Physician-Patient Relations | 6 | 2024 | 588 | 1.510 |
Why?
| | Medication Therapy Management | 3 | 2023 | 72 | 1.510 |
Why?
| | Child | 62 | 2026 | 22740 | 1.400 |
Why?
| | Outpatients | 3 | 2024 | 447 | 1.150 |
Why?
| | Child, Preschool | 37 | 2026 | 11868 | 1.090 |
Why?
| | Delivery of Health Care | 3 | 2023 | 948 | 1.040 |
Why?
| | Drug Interactions | 6 | 2024 | 405 | 1.020 |
Why?
| | Prescription Drugs | 3 | 2017 | 111 | 0.910 |
Why?
| | Epidermolysis Bullosa Dystrophica | 2 | 2023 | 41 | 0.910 |
Why?
| | Neurodevelopmental Disorders | 3 | 2019 | 229 | 0.850 |
Why?
| | Caregivers | 7 | 2026 | 1074 | 0.840 |
Why?
| | Pediatrics | 7 | 2025 | 1125 | 0.830 |
Why?
| | Infant | 29 | 2025 | 10091 | 0.830 |
Why?
| | Parents | 3 | 2026 | 1407 | 0.820 |
Why?
| | Adolescent | 37 | 2026 | 22577 | 0.800 |
Why?
| | Patient Care | 1 | 2024 | 120 | 0.750 |
Why?
| | Cholinergic Antagonists | 1 | 2022 | 24 | 0.740 |
Why?
| | Oral Health | 1 | 2024 | 139 | 0.740 |
Why?
| | Cross-Sectional Studies | 14 | 2024 | 5925 | 0.730 |
Why?
| | Sleep Wake Disorders | 2 | 2016 | 314 | 0.700 |
Why?
| | Inappropriate Prescribing | 1 | 2022 | 66 | 0.700 |
Why?
| | Humans | 82 | 2026 | 145783 | 0.680 |
Why?
| | Prescription Drug Overuse | 1 | 2020 | 10 | 0.660 |
Why?
| | Drug Utilization | 2 | 2019 | 168 | 0.650 |
Why?
| | Retrospective Studies | 32 | 2025 | 17330 | 0.630 |
Why?
| | Drug Prescriptions | 2 | 2020 | 288 | 0.630 |
Why?
| | Symptom Assessment | 1 | 2020 | 136 | 0.590 |
Why?
| | Drug Administration Schedule | 1 | 2021 | 782 | 0.590 |
Why?
| | Hospitalization | 6 | 2024 | 2461 | 0.570 |
Why?
| | Analgesics | 1 | 2020 | 231 | 0.560 |
Why?
| | Pharmaceutical Preparations | 2 | 2023 | 171 | 0.560 |
Why?
| | Ambulatory Care | 4 | 2023 | 610 | 0.550 |
Why?
| | Cohort Studies | 13 | 2024 | 6033 | 0.540 |
Why?
| | Drug Costs | 1 | 2019 | 117 | 0.530 |
Why?
| | Drug Monitoring | 1 | 2021 | 401 | 0.520 |
Why?
| | United States | 22 | 2025 | 16126 | 0.520 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2022 | 641 | 0.510 |
Why?
| | Critical Illness | 1 | 2024 | 900 | 0.510 |
Why?
| | Male | 44 | 2026 | 73011 | 0.510 |
Why?
| | Health Services Needs and Demand | 1 | 2019 | 280 | 0.510 |
Why?
| | Health Priorities | 1 | 2017 | 41 | 0.490 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 498 | 0.470 |
Why?
| | Attitude to Death | 4 | 2024 | 76 | 0.470 |
Why?
| | Self-Injurious Behavior | 3 | 2023 | 141 | 0.470 |
Why?
| | Female | 40 | 2026 | 79045 | 0.440 |
Why?
| | Home Care Services | 3 | 2025 | 284 | 0.440 |
Why?
| | Skin Neoplasms | 1 | 2022 | 853 | 0.440 |
Why?
| | Software | 1 | 2018 | 680 | 0.370 |
Why?
| | Emergency Service, Hospital | 4 | 2025 | 2383 | 0.370 |
Why?
| | Hospitals, Pediatric | 8 | 2025 | 558 | 0.360 |
Why?
| | Terminally Ill | 2 | 2010 | 40 | 0.360 |
Why?
| | Databases, Factual | 7 | 2024 | 1491 | 0.350 |
Why?
| | Esophageal Stenosis | 2 | 2025 | 60 | 0.350 |
Why?
| | Severity of Illness Index | 4 | 2020 | 2933 | 0.340 |
Why?
| | Algorithms | 2 | 2022 | 1851 | 0.340 |
Why?
| | Health Services Research | 3 | 2025 | 391 | 0.320 |
Why?
| | Analgesics, Opioid | 1 | 2019 | 1154 | 0.320 |
Why?
| | Biomedical Research | 1 | 2017 | 719 | 0.310 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 2399 | 0.310 |
Why?
| | Professional-Family Relations | 2 | 2009 | 154 | 0.280 |
Why?
| | Mortality | 2 | 2009 | 381 | 0.280 |
Why?
| | Child Mortality | 1 | 2007 | 16 | 0.260 |
Why?
| | Autopsy | 1 | 2007 | 94 | 0.260 |
Why?
| | Practice Patterns, Physicians' | 1 | 2017 | 1372 | 0.260 |
Why?
| | Patient Preference | 1 | 2010 | 223 | 0.250 |
Why?
| | Terminal Care | 2 | 2011 | 283 | 0.250 |
Why?
| | Palliative Care | 4 | 2026 | 1022 | 0.250 |
Why?
| | Epidermolysis Bullosa, Junctional | 1 | 2026 | 10 | 0.240 |
Why?
| | Grounded Theory | 1 | 2026 | 44 | 0.240 |
Why?
| | Infant, Newborn | 10 | 2026 | 6465 | 0.230 |
Why?
| | Medical History Taking | 1 | 2005 | 117 | 0.220 |
Why?
| | Law Enforcement | 1 | 2025 | 48 | 0.220 |
Why?
| | Child Welfare | 1 | 2007 | 233 | 0.220 |
Why?
| | Cause of Death | 1 | 2007 | 472 | 0.220 |
Why?
| | Police | 1 | 2025 | 45 | 0.220 |
Why?
| | Prevalence | 3 | 2024 | 2875 | 0.210 |
Why?
| | Pharmacists | 2 | 2025 | 258 | 0.210 |
Why?
| | Risk Assessment | 5 | 2020 | 3752 | 0.210 |
Why?
| | Ontario | 1 | 2024 | 90 | 0.200 |
Why?
| | Transition to Adult Care | 1 | 2026 | 103 | 0.200 |
Why?
| | Education, Medical, Undergraduate | 1 | 2007 | 208 | 0.200 |
Why?
| | House Calls | 1 | 2005 | 154 | 0.200 |
Why?
| | Professional Role | 1 | 2025 | 170 | 0.200 |
Why?
| | Pharmacogenomic Testing | 1 | 2024 | 63 | 0.200 |
Why?
| | Attitude of Health Personnel | 3 | 2024 | 1197 | 0.190 |
Why?
| | Cerebral Palsy | 1 | 2026 | 138 | 0.190 |
Why?
| | World Health Organization | 1 | 2023 | 104 | 0.190 |
Why?
| | Dilatation | 2 | 2025 | 73 | 0.190 |
Why?
| | Health Services Accessibility | 2 | 2025 | 1101 | 0.190 |
Why?
| | Qualitative Research | 3 | 2026 | 1683 | 0.190 |
Why?
| | Internship and Residency | 2 | 2011 | 1269 | 0.190 |
Why?
| | Dental Caries | 1 | 2024 | 173 | 0.190 |
Why?
| | Family | 1 | 2007 | 685 | 0.190 |
Why?
| | Patient Safety | 3 | 2023 | 356 | 0.190 |
Why?
| | Adult | 11 | 2026 | 40881 | 0.180 |
Why?
| | Health Equity | 1 | 2025 | 133 | 0.180 |
Why?
| | Logistic Models | 3 | 2024 | 2139 | 0.170 |
Why?
| | Mobile Applications | 1 | 2024 | 199 | 0.170 |
Why?
| | Seizures | 1 | 2005 | 485 | 0.170 |
Why?
| | Anemia | 1 | 2023 | 191 | 0.170 |
Why?
| | Canada | 2 | 2020 | 432 | 0.170 |
Why?
| | Patient Discharge | 3 | 2021 | 995 | 0.170 |
Why?
| | Child, Hospitalized | 1 | 2021 | 54 | 0.160 |
Why?
| | Age Factors | 4 | 2021 | 3346 | 0.160 |
Why?
| | Physicians | 1 | 2009 | 956 | 0.160 |
Why?
| | Behavioral Symptoms | 1 | 2020 | 41 | 0.160 |
Why?
| | Medication Errors | 2 | 2024 | 85 | 0.160 |
Why?
| | Multimorbidity | 1 | 2021 | 65 | 0.160 |
Why?
| | Pseudomonas aeruginosa | 1 | 2023 | 397 | 0.160 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2024 | 1752 | 0.150 |
Why?
| | Bronchiolitis | 1 | 2021 | 87 | 0.150 |
Why?
| | Data Collection | 2 | 2020 | 643 | 0.150 |
Why?
| | Pilot Projects | 1 | 2025 | 1898 | 0.140 |
Why?
| | Patient Care Team | 1 | 2025 | 697 | 0.140 |
Why?
| | Young Adult | 8 | 2026 | 14254 | 0.140 |
Why?
| | Decision Making | 1 | 2026 | 982 | 0.140 |
Why?
| | Psychotropic Drugs | 1 | 2019 | 78 | 0.140 |
Why?
| | Biopsy, Needle | 1 | 2019 | 185 | 0.140 |
Why?
| | Programming Languages | 1 | 2018 | 24 | 0.140 |
Why?
| | Fluoroscopy | 1 | 2018 | 180 | 0.130 |
Why?
| | Colorado | 2 | 2020 | 4556 | 0.130 |
Why?
| | North America | 1 | 2019 | 304 | 0.130 |
Why?
| | Age Distribution | 1 | 2019 | 404 | 0.130 |
Why?
| | Healthcare Disparities | 1 | 2025 | 736 | 0.130 |
Why?
| | Patient-Centered Care | 1 | 2023 | 547 | 0.130 |
Why?
| | Sex Distribution | 1 | 2019 | 388 | 0.130 |
Why?
| | Cardiac Volume | 1 | 1997 | 14 | 0.130 |
Why?
| | Critical Care | 1 | 2024 | 702 | 0.130 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2020 | 196 | 0.130 |
Why?
| | Vulnerable Populations | 1 | 2019 | 176 | 0.130 |
Why?
| | Suicidal Ideation | 1 | 2023 | 584 | 0.130 |
Why?
| | Electronic Health Records | 1 | 2025 | 1202 | 0.130 |
Why?
| | Case Management | 1 | 2017 | 68 | 0.130 |
Why?
| | Child Health | 1 | 2019 | 154 | 0.130 |
Why?
| | Diastole | 1 | 1997 | 146 | 0.130 |
Why?
| | Child Health Services | 3 | 2022 | 186 | 0.130 |
Why?
| | Fee-for-Service Plans | 1 | 2017 | 99 | 0.120 |
Why?
| | Nursing Staff, Hospital | 2 | 2011 | 143 | 0.120 |
Why?
| | Antiviral Agents | 1 | 2023 | 769 | 0.120 |
Why?
| | Esophagoscopy | 1 | 2018 | 223 | 0.120 |
Why?
| | Managed Care Programs | 1 | 2017 | 140 | 0.120 |
Why?
| | Influenza, Human | 1 | 2023 | 624 | 0.120 |
Why?
| | Esophagus | 2 | 2018 | 262 | 0.120 |
Why?
| | Data Interpretation, Statistical | 1 | 2018 | 368 | 0.120 |
Why?
| | Image Enhancement | 1 | 1997 | 200 | 0.120 |
Why?
| | Staphylococcal Infections | 1 | 2020 | 393 | 0.120 |
Why?
| | Drug Labeling | 1 | 2015 | 37 | 0.110 |
Why?
| | Survival Analysis | 1 | 2019 | 1378 | 0.110 |
Why?
| | Health Care Costs | 1 | 2019 | 425 | 0.110 |
Why?
| | Drug Therapy, Combination | 2 | 2018 | 1043 | 0.110 |
Why?
| | Sex Factors | 2 | 2019 | 2110 | 0.110 |
Why?
| | Pain | 1 | 2020 | 791 | 0.110 |
Why?
| | Pneumonia | 1 | 2021 | 636 | 0.110 |
Why?
| | Immunohistochemistry | 1 | 2019 | 1723 | 0.110 |
Why?
| | Anti-Bacterial Agents | 2 | 2022 | 1925 | 0.100 |
Why?
| | Insurance Claim Reporting | 1 | 2014 | 26 | 0.100 |
Why?
| | Utilization Review | 1 | 2014 | 39 | 0.100 |
Why?
| | Stomach | 1 | 2014 | 111 | 0.100 |
Why?
| | Autism Spectrum Disorder | 1 | 2020 | 423 | 0.100 |
Why?
| | Duodenum | 1 | 2014 | 77 | 0.100 |
Why?
| | Quality of Life | 2 | 2025 | 3211 | 0.100 |
Why?
| | Telemedicine | 1 | 2023 | 967 | 0.100 |
Why?
| | Mucous Membrane | 1 | 2014 | 128 | 0.100 |
Why?
| | Biomedical Technology | 1 | 2014 | 50 | 0.100 |
Why?
| | Neoplasms | 1 | 2009 | 2913 | 0.100 |
Why?
| | Patient Readmission | 2 | 2021 | 773 | 0.100 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2016 | 288 | 0.100 |
Why?
| | Hypnotics and Sedatives | 1 | 2016 | 222 | 0.100 |
Why?
| | Terminology as Topic | 1 | 2015 | 259 | 0.100 |
Why?
| | Interviews as Topic | 3 | 2026 | 916 | 0.100 |
Why?
| | Statistics as Topic | 1 | 2014 | 283 | 0.100 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2014 | 237 | 0.090 |
Why?
| | Lung Neoplasms | 1 | 2005 | 2668 | 0.090 |
Why?
| | Patient Admission | 1 | 2014 | 220 | 0.090 |
Why?
| | Incidence | 1 | 2019 | 2934 | 0.090 |
Why?
| | Quality Improvement | 1 | 2020 | 1296 | 0.090 |
Why?
| | Follow-Up Studies | 2 | 2019 | 5428 | 0.090 |
Why?
| | Endoscopy, Digestive System | 1 | 2013 | 142 | 0.090 |
Why?
| | Risk Factors | 4 | 2021 | 10919 | 0.090 |
Why?
| | Comorbidity | 3 | 2023 | 1662 | 0.080 |
Why?
| | Mental Disorders | 1 | 2020 | 1171 | 0.080 |
Why?
| | Organ Transplantation | 1 | 2014 | 253 | 0.080 |
Why?
| | Disease Progression | 1 | 2019 | 2865 | 0.080 |
Why?
| | Gastrointestinal Diseases | 1 | 2013 | 222 | 0.080 |
Why?
| | Bereavement | 1 | 2011 | 71 | 0.080 |
Why?
| | Anecdotes as Topic | 1 | 2010 | 7 | 0.080 |
Why?
| | Drug Overdose | 1 | 2014 | 375 | 0.070 |
Why?
| | Obesity | 1 | 2023 | 3118 | 0.070 |
Why?
| | Cardiology | 1 | 2011 | 362 | 0.070 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2007 | 1420 | 0.070 |
Why?
| | Pharmacoepidemiology | 2 | 2019 | 23 | 0.070 |
Why?
| | Domestic Violence | 1 | 2008 | 51 | 0.060 |
Why?
| | Predictive Value of Tests | 2 | 2023 | 2123 | 0.060 |
Why?
| | Shellfish | 1 | 2005 | 6 | 0.060 |
Why?
| | Humanism | 1 | 2005 | 6 | 0.060 |
Why?
| | Health Care Surveys | 2 | 2017 | 536 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 1 | 1997 | 3916 | 0.050 |
Why?
| | Anaphylaxis | 1 | 2005 | 102 | 0.050 |
Why?
| | Adrenal Cortex Hormones | 1 | 2007 | 484 | 0.050 |
Why?
| | Adaptation, Psychological | 1 | 2010 | 719 | 0.050 |
Why?
| | Residence Characteristics | 1 | 2007 | 375 | 0.050 |
Why?
| | Cytochrome P-450 CYP2D6 | 1 | 2024 | 32 | 0.050 |
Why?
| | Deglutition Disorders | 1 | 2025 | 154 | 0.050 |
Why?
| | Longitudinal Studies | 2 | 2022 | 2968 | 0.050 |
Why?
| | Heart Defects, Congenital | 1 | 2011 | 910 | 0.050 |
Why?
| | Food Hypersensitivity | 1 | 2005 | 164 | 0.050 |
Why?
| | Sensitivity and Specificity | 2 | 2018 | 2000 | 0.050 |
Why?
| | Hospitals | 1 | 2007 | 733 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2023 | 421 | 0.040 |
Why?
| | Mupirocin | 1 | 2020 | 7 | 0.040 |
Why?
| | Nursing Homes | 1 | 2023 | 174 | 0.040 |
Why?
| | Communication | 2 | 2023 | 977 | 0.040 |
Why?
| | Consensus | 1 | 2023 | 479 | 0.040 |
Why?
| | Iron | 1 | 2023 | 359 | 0.040 |
Why?
| | Prognosis | 1 | 2009 | 4330 | 0.040 |
Why?
| | Anxiety Disorders | 1 | 2023 | 371 | 0.040 |
Why?
| | Pharmacovigilance | 1 | 2019 | 24 | 0.040 |
Why?
| | Primary Health Care | 2 | 2022 | 1737 | 0.040 |
Why?
| | Health Expenditures | 1 | 2020 | 194 | 0.030 |
Why?
| | Adolescent Health Services | 1 | 2019 | 74 | 0.030 |
Why?
| | Clinical Competence | 1 | 2005 | 1247 | 0.030 |
Why?
| | Health Maintenance Organizations | 1 | 2017 | 105 | 0.030 |
Why?
| | Observer Variation | 1 | 2018 | 357 | 0.030 |
Why?
| | Models, Theoretical | 2 | 2011 | 560 | 0.030 |
Why?
| | Staphylococcus aureus | 1 | 2020 | 454 | 0.030 |
Why?
| | Mental Health Services | 1 | 2022 | 475 | 0.030 |
Why?
| | Health Personnel | 1 | 2023 | 757 | 0.030 |
Why?
| | Reference Values | 1 | 1997 | 798 | 0.030 |
Why?
| | Anxiety | 1 | 2023 | 1122 | 0.030 |
Why?
| | Global Health | 1 | 2019 | 403 | 0.030 |
Why?
| | Rural Population | 1 | 2020 | 661 | 0.030 |
Why?
| | Stomach Diseases | 1 | 2014 | 20 | 0.030 |
Why?
| | Clinical Coding | 1 | 2014 | 29 | 0.030 |
Why?
| | Endoscopes, Gastrointestinal | 1 | 2013 | 13 | 0.020 |
Why?
| | Failure to Thrive | 1 | 2013 | 28 | 0.020 |
Why?
| | Mental Health | 1 | 2020 | 796 | 0.020 |
Why?
| | Patient Acceptance of Health Care | 1 | 2020 | 883 | 0.020 |
Why?
| | Middle Aged | 3 | 2018 | 36309 | 0.020 |
Why?
| | Tertiary Care Centers | 1 | 2013 | 195 | 0.020 |
Why?
| | Abdominal Pain | 1 | 2013 | 149 | 0.020 |
Why?
| | Vena Cava, Superior | 1 | 2011 | 25 | 0.020 |
Why?
| | Computers | 1 | 2011 | 66 | 0.020 |
Why?
| | Celiac Disease | 1 | 2014 | 311 | 0.020 |
Why?
| | Models, Anatomic | 1 | 2011 | 87 | 0.020 |
Why?
| | Biopsy | 1 | 2014 | 1082 | 0.020 |
Why?
| | Anastomosis, Surgical | 1 | 2011 | 163 | 0.020 |
Why?
| | Vena Cava, Inferior | 1 | 2011 | 83 | 0.020 |
Why?
| | Gastroesophageal Reflux | 1 | 2013 | 237 | 0.020 |
Why?
| | Models, Cardiovascular | 1 | 2011 | 196 | 0.020 |
Why?
| | Eosinophilic Esophagitis | 1 | 2014 | 332 | 0.020 |
Why?
| | Prospective Studies | 1 | 2022 | 8078 | 0.020 |
Why?
| | Blood Flow Velocity | 1 | 2011 | 421 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2013 | 1547 | 0.020 |
Why?
| | Length of Stay | 1 | 2015 | 1350 | 0.020 |
Why?
| | Pennsylvania | 1 | 2009 | 138 | 0.020 |
Why?
| | Nurses | 1 | 2011 | 171 | 0.020 |
Why?
| | Computer Simulation | 1 | 2011 | 1003 | 0.020 |
Why?
| | Nurse-Patient Relations | 1 | 2007 | 67 | 0.010 |
Why?
| | Pulmonary Artery | 1 | 2011 | 1129 | 0.010 |
Why?
| | Regression Analysis | 1 | 2008 | 1001 | 0.010 |
Why?
| | Hospital Mortality | 1 | 2009 | 1038 | 0.010 |
Why?
| | Kidney Diseases | 1 | 2007 | 426 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2018 | 11794 | 0.010 |
Why?
|
|
Feinstein's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|